AIMPLAS and FAKOLITH Develop Safer Coatings in Response to Regulatory Changes Concerning Bisphenol A and Endocrine Disruptors

Growing evidence regarding the negative health effects of Bisphenol A and other endocrine disruptors is forcing industry to develop safer BPA-free alternatives with undetectable migration levels.

The SAFE-ED Coatings project will enable the development of up to four coating systems suitable for direct and indirect contact with food, beverages, drinking water and construction applications.

Image Credit: AIMPLAS

International concern over the presence of endocrine disruptors (EDs), especially Bisphenol A (BPA) and its derivatives, has reached unprecedented levels. These persistent substances, capable of altering the hormonal and reproductive systems of humans and animals, are undergoing intensive scientific and regulatory review.

In Europe, the European Food Safety Authority (EFSA) has recommended reducing the tolerable daily intake of BPA by 100,000 times, while US authorities (FDA) are also studying new limits. At the same time, regulations such as Directive (EU) 2020/2184, the recent Royal Decree 3/2023 in Spain, and ongoing work by ECHA point clearly towards tighter restrictions affecting food, beverages, drinking water and all types of industrial and consumer products.

In this context, sectors highly dependent on bisphenol-based resins and additives – such as epoxy coatings – are facing an unprecedented transformation. The SAFE-ED Coatings project, coordinated by FAKOLITH with the participation of AIMPLAS, the Plastics Technology Centre, was launched to provide a technical, health and regulatory response to this new scenario. Its objective is to develop up to four innovative coating systems capable of reducing endocrine disruptor migration to undetectable levels (< 1 ppb) or eliminating it entirely, while maintaining the functionality required for use in construction and civil engineering surfaces, food industry installations (indirect contact), direct contact with drinking water, and direct contact with food and beverages.

Marta García, R&D&I Director at FAKOLITH, stated that “the speed at which legislation is evolving means that many existing solutions are becoming obsolete. The coatings sector needs safe and functional alternatives, and SAFE-ED Coatings will make it possible to anticipate these changes with viable technologies for industry and properly certified market-ready solutions.”

Meanwhile, Ma Carmen Moreno, researcher at the Food Contact and Packaging Laboratory at AIMPLAS, explained that “we are adapting and expanding our testing methodologies for coatings in order to meet the new regulatory limits.”

FAKOLITH, a specialist in coatings for surfaces in direct and indirect contact with food, beverages and drinking water, is leading the development and formulation of the new systems, focusing on the principles of elimination, reduction and encapsulation of endocrine disruptors. The project began with a pool of no fewer than 80 raw materials, of which at least 60 (75%) are expected to meet the requirements for direct food contact while also being functional for the new coating systems.

Advanced Methodologies

AIMPLAS is contributing its expertise in legislation and risk assessment. The technology center has evaluated the regulatory documentation of the raw materials, defined the necessary tests in accordance with current regulations and upcoming updates, and is applying advanced methodologies to adapt standards applicable to coatings and achieve increasingly stringent regulatory limits (< 1 ppb).

Faced with one of the most significant regulatory changes in recent years in the field of food safety, SAFE-ED Coatings is positioned as a strategic project that will enable industry to move towards high-performance, sustainable and safe coatings, ensuring compliance with both current and future regulations.

SAFE-ED Coatings will have a direct impact on sectors particularly exposed to the new restrictions, such as the food industry, construction, civil engineering, healthcare and drinking water facilities. The project will strengthen safety in surfaces that come into direct and indirect contact with food, beverages and drinking water through the drastic reduction and elimination of endocrine disruptor migration. In addition, it will promote the incorporation of more sustainable alternatives based on bio-based materials, ensure the operational continuity of industrial applications affected by the recent prohibition and restriction of bisphenols, and facilitate knowledge transfer to manufacturers, applicators and the entire specialized coatings value chain.

The project will conclude at the end of 2026 and is funded by the European Union – NextGenerationEU through the Recovery, Transformation and Resilience Plan, with the support of the State Research Agency (AEI) of the Spanish Ministry of Science, Innovation and Universities.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AIMPLAS. (2026, June 18). AIMPLAS and FAKOLITH Develop Safer Coatings in Response to Regulatory Changes Concerning Bisphenol A and Endocrine Disruptors. AZoM. Retrieved on June 20, 2026 from https://www.azom.com/news.aspx?newsID=65545.

  • MLA

    AIMPLAS. "AIMPLAS and FAKOLITH Develop Safer Coatings in Response to Regulatory Changes Concerning Bisphenol A and Endocrine Disruptors". AZoM. 20 June 2026. <https://www.azom.com/news.aspx?newsID=65545>.

  • Chicago

    AIMPLAS. "AIMPLAS and FAKOLITH Develop Safer Coatings in Response to Regulatory Changes Concerning Bisphenol A and Endocrine Disruptors". AZoM. https://www.azom.com/news.aspx?newsID=65545. (accessed June 20, 2026).

  • Harvard

    AIMPLAS. 2026. AIMPLAS and FAKOLITH Develop Safer Coatings in Response to Regulatory Changes Concerning Bisphenol A and Endocrine Disruptors. AZoM, viewed 20 June 2026, https://www.azom.com/news.aspx?newsID=65545.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.